Programs
· 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door · 1:1 practitioner-led care · All necessary supplies included · MD-designed protocols · Medication shipped discreetly to your door
Disclaimer: AOD-9604 is an investigational peptide. Claims regarding metabolic support or fat loss have not been evaluated by the FDA. Individual results vary significantly. These compounds must be used under strict clinical supervision as part of a personalized, provider-led research protocol.

AOD-9604/MOTS-C

Investigational peptide combination that may support fat metabolism signaling and mitochondrial energy efficiency via metabolic protocols.

How It Feels

  • A gradual, steady shift in body composition without stimulant-like effects
  • Improved sense of physical output and training capacity over time
  • Subtle increase in “metabolic drive” during activity and movement
  • A leaner, more efficient feeling due to a full protocol cycle

Four Rules for Success

  • Use only within a clinician-directed investigational protocol
  • Maintain consistency across the full cycle for best metabolic response
  • Do not adjust timing or dosing without supervision
  • Support protocol with nutrition and recovery alignment

 

PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES
PROVIDER-SUPPORTED PROGRAMS
MEDICATION SHIPPED DISCREETLY TO YOUR DOOR
1:1 PRACTITIONER-LED CARE
ALL NECESSARY SUPPLIES ALWAYS FREE
BEST MEDICATION PRICES

The Science Behind AOD-9604 + MOTS-C

AOD-9604 is a modified HGH fragment studied for selective lipolysis signaling without broader growth hormone activity. MOTS-C is a mitochondrial peptide involved in AMPK-related pathways that regulate cellular energy balance and metabolic flexibility.

Usage & Dosage

  • Subcutaneous administration only under supervision
  • Commonly structured in cycling protocols (e.g., intermittent use phases)
  • Morning use often preferred in fasted state within protocol design
  • Timing and dose must be clinician-determined
  • Individual response may vary
Disclaimer: AOD-9604 is an investigational peptide. Claims regarding metabolic support or fat loss have not been evaluated by the FDA. Individual results vary significantly. These compounds must be used under strict clinical supervision as part of a personalized, provider-led research protocol.